Clinical Trial

Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension

Study acronym: HYPOPARK
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Phase 1 objective: test the feasibility of using a 3Tesla MRI scanner instead of a 7Tesla MRI scanner to measure brainstem responses to LBNP in healthy participants. Phase 2 primary objective: compare the brainstem responses to LBNP in patients with PD associated with OH to PD patients without OH using BOLD fMRI
Trial Details
NCT Number NCT07139756
Lead Sponsor Centre Hospitalier Universitaire Vaudois
Collaborators: Ecole Polytechnique Fédérale de Lausanne, University Hospital, Geneva
Conditions Parkinson Disease, Orthostatic Hypotension
Enrollment 130 participants
Start Date 2025-10-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-24